APA (7th ed.) Citation

Toedebusch, R. G., Ruegsegger, G. N., Braselton, J. F., Heese, A. J., Hofheins, J. C., Childs, T. E., . . . Booth, F. W. (2016). AMPK agonist AICAR delays the initial decline in lifetime-apex VO2 peak, while voluntary wheel running fails to delay its initial decline in female rats. Physiological Genomics, 48(2), 101. https://doi.org/10.1152/physiolgenomics.00078.2015

Chicago Style (17th ed.) Citation

Toedebusch, Ryan G., Gregory N. Ruegsegger, Joshua F. Braselton, Alexander J. Heese, John C. Hofheins, Tom E. Childs, John P. Thyfault, and Frank W. Booth. "AMPK Agonist AICAR Delays the Initial Decline in Lifetime-apex VO2 Peak, While Voluntary Wheel Running Fails to Delay Its Initial Decline in Female Rats." Physiological Genomics 48, no. 2 (2016): 101. https://doi.org/10.1152/physiolgenomics.00078.2015.

MLA (9th ed.) Citation

Toedebusch, Ryan G., et al. "AMPK Agonist AICAR Delays the Initial Decline in Lifetime-apex VO2 Peak, While Voluntary Wheel Running Fails to Delay Its Initial Decline in Female Rats." Physiological Genomics, vol. 48, no. 2, 2016, p. 101, https://doi.org/10.1152/physiolgenomics.00078.2015.